" Comparative Evaluation of Aggressive Gap Arthroplasty With Minimal Gap Arthroplasty in the Management of TMJ Ankylosis "

the most commonly used protocol in the management of TMJ ankylosis is Kabans protocol in which 1.5 to 2 cm aggressive resection of bone is recommended which may lead to gap between cranial base and condyle of mandible.1 However, there are certain disadvantages associated with aggressive gap arthroplasty such as pseudo articulation with shortening of the mandibular ramus, premature occlusion on the affected side with a contralateral open bite in unilateral cases,2 in bilateral cases gagging of the posterior teeth and anterior open bite.3 Few studies in the literature available agreed that minimum gap arthroplasty i.e. 5 to 8 mm of gap is sufficient for TMJ movements in all planes and recurrence of ankylosis is likely to be prevented by interposed material (graft)4 .So, a randomized control study to compare outcomes of minimal gap arthroplasty with aggressive gap arthroplasty for management of TMJ ankylosis is planned.

Study Overview

Status

Recruiting

Conditions

Detailed Description

A standardize protocol for each patient will be followed that comprises of case selection, clinincal evaluation, radiographic assessment,treatment planning and measurement of varius parameters.

  • Medical and Dental history of the patient will be obtained.
  • A written consent form signed by the patient, will be obtained.
  • Case evaluation will be done which will include clinical and radiographic evaluation Based on the case evaluation, surgical treatment of ankylosis will be performed . patient will be randomized into the following two groups. Group A -minimal gap arthroplasty for management of Tmj ankylosis Group B -aggressive gap arthroplasty for management of TMJ ankylosis A minimum of 6 subjects per group completing the study would be giving a good external validity to the present study.

    1. All the patients were evaluated with history, clinical and radiological examinations (panoramic and CT scans). Informed consent will be obtaine from all the patients.
    2. In both groups, all the patients will be operated by an experienced surgeon.The data acquisition will be done by a resident who will be kept blind for group allocation.

    3. In group 1 cases treatment of TMJ ankylosis will be done by minimal gap arthroplasty and in group 2 cases treatment of TMJ ankylosis will be done by aggressive gap arthroplasty 4. both groups cases will be evaluated preoperatively ,intraoperatively and postoperatively Follow-up visits will be at 1, 3, and 6 months 5. preoperative and postoperative evaluation will be done clinically ( mouth opening ,protrusive movement, laterotrusive movement ) , radiologically (OPG, CTscan) .

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Haryana
      • Rohtak, Haryana, India, 124001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Medically healthy adult(ASA Classification I-II)
  • Any age group
  • Sawhneys classification type IV
  • Unilateral ankylosis
  • Written informed consent

Exclusion Criteria:

  • Any syndromic patient
  • Recurrence cases
  • Sawhneys classification type I,II,III

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: aggresive gap arthoplasty
control group- aggressive gap arthroplasty(15 to 20 mm) for management of TMJ ankyosis
Comparative evaluation of aggressive gap arthroplasty with minimal gap arthroplasty in the management of TMJ ankylosis
Active Comparator: minimal gap arthoplasty
experimental group-minimal gap arthroplasty(5 to 8mm) for management of TMJ ankylosis
Comparative evaluation of aggressive gap arthroplasty with minimal gap arthroplasty in the management of TMJ ankylosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mouth opening
Time Frame: T0- preoperatively
maximal interincisal distance on opening mouth widely.
T0- preoperatively
mouth opening
Time Frame: T1- 24hr after surgical intervention
maximal interincisal distance on opening mouth widely.
T1- 24hr after surgical intervention
mouth opening
Time Frame: T2- 1 month after surgical intervention
maximal interincisal distance on opening mouth widely.
T2- 1 month after surgical intervention
mouth opening
Time Frame: T3- 3 month after surgical intervention
maximal interincisal distance on opening mouth widely.
T3- 3 month after surgical intervention
mouth opening
Time Frame: T4- 6 month after surgical intervention
maximal interincisal distance on opening mouth widely.
T4- 6 month after surgical intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Protrusive movement
Time Frame: T0- preoperatively
maximal protrusive movement on mandibular advancement
T0- preoperatively
Protrusive movement
Time Frame: T1- 24hr after surgical intervention
maximal protrusive movement on mandibular advancement
T1- 24hr after surgical intervention
Protrusive movement
Time Frame: T2- 1 month after surgical intervention
maximal protrusive movement on mandibular advancement
T2- 1 month after surgical intervention
Protrusive movement
Time Frame: T3- 3 month after surgical intervention
maximal protrusive movement on mandibular advancement
T3- 3 month after surgical intervention
Protrusive movement
Time Frame: T4- 6 month after surgical intervention
maximal protrusive movement on mandibular advancement
T4- 6 month after surgical intervention
Laterotrusive movement
Time Frame: T0- preoperatively
maximal lateral movement on mandibular excursion
T0- preoperatively
Laterotrusive movement
Time Frame: T1- 24hr after surgical intervention
maximal lateral movement on mandibular excursion
T1- 24hr after surgical intervention
Laterotrusive movement
Time Frame: T2- 1 month after surgical intervention
maximal lateral movement on mandibular excursion
T2- 1 month after surgical intervention
Laterotrusive movement
Time Frame: T3- 3 month after surgical intervention
maximal lateral movement on mandibular excursion
T3- 3 month after surgical intervention
Laterotrusive movement
Time Frame: T4- 6 month after surgical intervention
maximal lateral movement on mandibular excursion
T4- 6 month after surgical intervention
Any complication
Time Frame: T0- preoperatively
Any complication after surgery
T0- preoperatively
Any complication
Time Frame: T1- 24hr after surgical intervention
Any complication after surgery
T1- 24hr after surgical intervention
Any complication
Time Frame: T2- 1 month after surgical intervention
Any complication after surgery
T2- 1 month after surgical intervention
Any complication
Time Frame: T3- 3 month after surgical intervention
Any complication after surgery
T3- 3 month after surgical intervention
Any complication
Time Frame: T4- 6 month after surgical intervention
Any complication after surgery
T4- 6 month after surgical intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

September 30, 2024

Study Registration Dates

First Submitted

November 8, 2022

First Submitted That Met QC Criteria

November 8, 2022

First Posted (Actual)

November 16, 2022

Study Record Updates

Last Update Posted (Actual)

November 16, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PGIDS/BHRC/22/41 NILESH BAGDE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthoplasty

Subscribe